Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05330611 · ClinicalTrials.gov registry record · NA
Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT05330611: Completed NA study, sponsored by Stanford University.
NCT05330611 is a NA study that has completed, run by Stanford University. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05330611, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this research study is to examine the effectiveness of using the Iovera Smart Time 190, for ultrasound-guided cryoneurolysis, in trauma patients 18-64 years old with rib fractures that are not candidates for surgical stabilization. This will offer patients the benefits of cryoneurolysis of the intercostal nerves, thereby providing short and long term pain control while their ribs heal. The Iovera Smart Tip 190 is FDA approved for cryoneurolysis.
Interventions
- OTHER Standard of Care
- DEVICE Cryoneurolysis of Intercostal Nerves
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2023-02-21 |
| Est. Completion | 2026-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05330611
The ClinicalTrials.gov registry entry for NCT05330611 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05330611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05330611 about?
NCT05330611 is a clinical study titled "Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis". The purpose of this research study is to examine the effectiveness of using the Iovera Smart Time 190, for ultrasound-guided cryoneurolysis, in trauma patients 18-64 years old with rib fractures that are not candidates for surgical stabilization. This will offer patients the benefits of cryoneurolys...
What is the current status of trial NCT05330611?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2023-02-21. Estimated completion is 2026-02-02.
What interventions are being tested in trial NCT05330611?
The interventions under investigation include: Standard of Care (OTHER), Cryoneurolysis of Intercostal Nerves (DEVICE).
Who is sponsoring clinical trial NCT05330611?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.